Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Cardiac Biomarkers Testing Market Through 2029?

In recent times, there has been significant growth in the market size for cardiac biomarkers testing. The market is projected to expand from $13.48 billion in 2024 to $14.95 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.9%. Factors contributing to the growth in the previous period include a rise in cardiovascular diseases, an aging population, initiatives concerning awareness and education, government schemes and health policies, and an upward trend in healthcare expenditure.

In the coming years, the cardiac biomarkers testing market is anticipated to experience swift expansion. The market is projected to escalate to “$23.24 billion in 2029, boasting a compound annual growth rate (CAGR) of 11.7%. Factors driving this incremental growth during the forecast period are the popularity of personalized medicine, the escalating worldwide prevalence of cardiovascular diseases, the incorporation of artificial intelligence in diagnostics, the broadening spectrum of point-of-care testing, and the increased focus on early detection of diseases. The forecast period also sees key trends such as technological progression, improvements in AI-supported diagnostics, the expansion of point-of-care testing (POCT), enhanced multiplexing capabilities, and the discovery and validation of biomarkers.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp

What Market Forces Are Driving The Cardiac Biomarkers Testing Sector In 2025 And Beyond?

The escalating occurrence of ailments related to the heart and blood vessels is predicted to propel the cardiac biomarkers testing market’s growth. Such diseases can significantly impact the heart and blood vessels, increasing the need for cardiac biomarker tests which can promptly discern the intensity and scale of a heart attack through biomarker levels. Consequently, increased heart-related diseases will boost the demand for these tests. For example, projections from the American College of Cardiology, a prominent U.S medical body in August 2022, suggest a striking rise in cardiovascular risk factors and disease in the country by 2060. Thus, the growing frequency of cardiovascular diseases is fuelling the expansion of the cardiac biomarkers testing market.

How Is The Global Cardiac Biomarkers Testing Market Categorized By Segments?

The cardiac biomarkers testing market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass

2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)

3) By Myoglobin: Total Myoglobin

4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)

5) By Ischemia Modified Albumin (IMA): IMA Levels

6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2

How Are Key Trends Driving Expansion In The Cardiac Biomarkers Testing Industry?

Major players in the cardiac biomarker testing sector are leveraging strategic collaborations to offer technological solutions for early detection of heart diseases and enhancing patient outcomes. These strategic alliances are encouraging cooperation among companies, facilitating the creation of groundbreaking diagnostics, broadening their market presence, and hastening the access to technologically advanced testing solutions for enhanced cardiac care. For instance, MediBuddy, an Indian healthcare technology firm offering a wide-ranging platform for telehealth services, comprehensive health management, and insurance-related support, established a collaboration with Philips, a Dutch multinational conglomerate, in September 2024. The aim of this partnership is to fortify cardiac care within India by integrating Philips’ HeartPrint technology, therefore allowing regular checks and risk evaluation of cardiac health. This innovative way of approach endows users with advanced tools available on MediBuddy’s platform, thereby promoting proactive cardiac health management and improved outcomes.

Which Firms Are Considered Leaders In The Cardiac Biomarkers Testing Market Space?

Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

What Role Do Regional Policies And Investments Play In Cardiac Biomarkers Testing Market Expansion?

North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9436&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model